Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
5(28%)
Results Posted
43%(3 trials)

Phase Distribution

Ph phase_2
4
22%
Ph phase_1
3
17%
Ph phase_3
5
28%
Ph not_applicable
5
28%

Phase Distribution

3

Early Stage

4

Mid Stage

5

Late Stage

Phase Distribution17 total trials
Phase 1Safety & dosage
3(17.6%)
Phase 2Efficacy & side effects
4(23.5%)
Phase 3Large-scale testing
5(29.4%)
N/ANon-phased studies
5(29.4%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

5

trials recruiting

Total Trials

18

all time

Status Distribution
Active(5)
Completed(7)
Other(6)

Detailed Status

Completed7
unknown6
Recruiting5

Development Timeline

Analytics

Development Status

Total Trials
18
Active
5
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 13 (17.6%)
Phase 24 (23.5%)
Phase 35 (29.4%)
N/A5 (29.4%)

Trials by Status

recruiting528%
completed739%
unknown633%

Recent Activity

Clinical Trials (18)

Showing 18 of 18 trials
NCT06719700Phase 2

Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small Cell Lung Cancer

Recruiting
NCT04155034Phase 3

S1827 (MAVERICK) Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients With Small Cell Lung Cancer

Recruiting
NCT05651802Not Applicable

PCI and Brain MRI Follow-up vs Brain MRI Follow-up Alone in Limited-stage SCLC Patients

Recruiting
NCT04790253Not Applicable

PRophylactic Cerebral Irradiation or Active MAgnetic Resonance Imaging Surveillance in Small-cell Lung Cancer Patients (PRIMALung Study)

Recruiting
NCT01603849Not Applicable

Prophylactic Cranial Irradiation in Patients With Lung Adenocarcinoma With High Risk of Brain Metastasis

Completed
NCT04947774

Prophylactic Cranial Irradiation in Extensive-stage Small Cell Lung Cancer

Unknown
NCT04829708Phase 3

Efficacy and Safety of Prophylactic Cranial Irradiation Versus MRI Surveillance in Patients With Limited-stage Small Cell Lung Cancer Who Achieved Remission After First-line Chemoradiotherapy

Recruiting
NCT00866307Phase 1

Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011)

Completed
NCT04535739Phase 3

PCI for Patients With ES-SCLC After RCT:a Prospective Randomized Study

Unknown
NCT01055197Phase 2

Radiation Therapy in Treating Patients With Extensive Stage Small Cell Lung Cancer

Completed
NCT03523234Not Applicable

Neoadjuvant Therapy Combined With Radical Surgery for the Treatment of Small Cell Lung Cancer (SCLC) in II and IIIA Stage

Unknown
NCT01553916Phase 1

Neuroprotective Effects of Lithium in Patients With Small Cell Lung Cancer Undergoing Radiation Therapy to the Brain

Completed
NCT02448576Not Applicable

PCI in Advanced Triple Negative Breast Cancer Patients Who Response to 1st Line Chemotherapy

Unknown
NCT00984997Phase 2

Combined Modality Treatment for Resectable Non-Small Cell Superior Sulcus Tumors

Completed
NCT02772107Phase 2

Temozolomide as Maintenance Therapy Following Induction Chemotherapy in Extensive Stage Small Cell Lung Cancer

Unknown
NCT01282437Phase 3

Prophylactic Cranial Irradiation (PCI) vs Observation in Stage III NSCLC

Completed
NCT00916877Phase 1

Prophylactic Cranial Irradiation in Patients With HER-2-Positive Metastatic Breast Cancer

Completed
NCT01158170Phase 3

Prophylactic Cranial Irradiation in Erlotinib/Gefitinib-responders With Non-small Cell Lung Cancer (NSCLC) (RT1001)

Unknown

All 18 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
18